Lisata Therapeutics Announces Upcoming Financial Results Event

Author: Logan Wright Updated: 02-20-2025 08:31 AM

Lisata Therapeutics Prepares for Financial Results Announcement

Lisata Therapeutics, Inc. (NASDAQ: LSTA), a clinical-stage pharmaceutical company making strides in innovative cancer therapies, is set to report its financial performance for the full year ending December 31, 2024. The announcement will occur on February 27, 2025, following the conclusion of market trading.

Details about the Upcoming Announcement

The company will provide insights into its financial status during a conference call scheduled for 4:30 p.m. Eastern Time on the same day. Participants interested in joining this call must pre-register via the designated link provided by the company. This step ensures they receive all necessary dial-in information and can seamlessly participate in the discussion.

What to Expect from Lisata Therapeutics

During the conference call, Lisata Therapeutics will likely share significant updates regarding its current projects and strategic direction, as well as address questions from investors. The anticipated release of the financial results marks a critical moment for the company, showcasing the progress it has made in clinical trials and product developments over the past year.

About Lisata's Innovative Therapies

Lisata Therapeutics is on the forefront of developing unique therapies targeting advanced solid tumors and other severe diseases. Their investigational treatment, certepetide, is designed to facilitate enhanced penetration of anti-cancer drugs directly into the tumors, potentially revolutionizing the treatment strategies available today.

What’s Next for Lisata Therapeutics?

Looking ahead, Lisata has ambitious plans for the coming years. The company aims to hit various milestones in its ongoing and upcoming clinical trials. With expectations of funding supporting operations into mid-2026, Lisata appears poised to deliver vital data that will inform both the market and its investors about product efficacy and safety.

Investor Relations

For inquiries regarding investment opportunities or investor relations, interested parties are encouraged to reach out to John Menditto, Vice President of Investor Relations at Lisata Therapeutics. He is available via phone or email, providing a direct line for any concerns or questions regarding the company's future prospects.

Frequently Asked Questions

When will Lisata Therapeutics report its financial results?

Lisata Therapeutics will report its financial results for the year ending December 31, 2024, on February 27, 2025.

How can investors participate in the conference call?

Investors can participate by registering through the link provided by Lisata Therapeutics to receive dial-in details.

What is certepetide?

Certepetide is an investigational drug developed by Lisata to enhance the targeted delivery of anti-cancer treatments to solid tumors.

Who can I contact for investor relations?

John Menditto, Vice President of Investor Relations, can be reached at Lisata Therapeutics for investor inquiries.

What are the company’s future plans?

Lisata Therapeutics plans to announce various milestones over the next 1.5 years, with funding anticipated to last until the second quarter of 2026.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.